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Newspaper and television ads extol the ben-
efits of a multitude of drugs and supplements,
diet products, and flavor enhancers. People take
herbal remedies to fight everything from a cold
to depression, if those don’t work, they obtain a
prescription for one of the many drugs to ele-
vate or alter their mood. Nobody knows yet the
long-term effects of all these substances on the
human body, and in particular on the highly
vulnerable perinate. What may be therapeutic
or safe for the mother, could be toxic to the
fetus and nursing infant. Many of these com-
pounds are too new to have been studied for a
long period of time.
There are two substances that have been
widely available for many years, and they, for
25 years, have been one of the subjects of Dr.
Bernard Shapiro’s funded research. Shapiro,
professor of biochemistry, has studied the
influence of MSG on prenatal and perinatal
development. Fifteen years ago, he added the
drug phenobarbital to his investigations. Why
those two? MSG, commonly known as
monosodium glutamate, is a food additive that
cannot be avoided. It’s in prepared foods, and
has been widely used in the United States since
the 1940s as a flavor enhancer—it is estimated
that Americans consume 200 million lbs. of
MSG or related products annually. Pheno-
barbital, a barbiturate, is frequently prescribed
to infants in intensive care and to pregnant
women for a variety of commonly occurring
maladies, among them convulsive disorders
that complicate one out of every 200 pregnan-
cies. Prescriptions for pregnant women were
particularly common between the 1950s and
1970s exposing more than 23 million children
in the United States alone. Neither MSG nor
phenobarbital produce visible birth defects,
however, it is thought that they interfere with
the production of a number of liver enzymes,
known as CYPs that are vital to the body’s abil-
ity to metabolize drugs and other potentially
toxic substances.
The expression of these drug metabolizing
enzymes is controlled by growth hormone pro-
duced by the pituitary. Levels of the hormone
in males and females are different as males
secrete the hormone in an episodic on-off
rhythm with periods where the hormone can-
not be detected. Women produce growth hor-
mone continuously and it is always present in
circulation. Because of these profiles, the levels
of drug metabolizing enzymes are different in
males and females; this may in part explain the
difference in response to drugs, for example
women take longer to emerge from anesthesia
than men. To complicate matters, levels of
growth hormone decline as a person ages.
In earlier studies, Dr. Shapiro’s group had
shown that neonatal administration of normal,
exposure-like levels of both phenobarbital and
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Lithotripsy, the fragmentation of bladder-
stones by shock waves, is an established treat-
ment in human medicine. Now these shock
waves are utilized in equine medicine to help
heal specific ligament and bone injuries. Dr.
Olga Seco, lecturer in sports medicine and
imaging, and other ultrasound specialists at the
Allam Center for Equine Sports Medicine at
New Bolton Center are compiling data on
horses they are treating with Extracorporeal
High Energy Shock Wave Therapy (ESWT).
The Scott Equine Sports Medicine Building
houses the ESWT equipment. Horses with sus-
pensory ligament desmitis and stress fractures,
and other musculoskeletal problems are treated
with ESWT. In the condition known as suspen-
sory ligament desmitis, the ligament originat-
ing in the palmar/plantar aspect of the canon
bone has sustained an injury. This injury can
affect only the ligament, or have an associated
avulsion fracture (piece of bone pulled up at
the area of attachment of the ligament by the
stress caused by the pulling on the ligament). A
stress fracture is an incomplete fracture that
occurs as the result of repetitive overload and
microfractures in one area of the bone. They
frequently occur in the dorsal aspect of the
canon bone in thoroughbred racehorses.
ESWT is thought to speed healing as well as
relieve pain. Pulsated pressure waves (shock
waves; not electric) are sent to the targeted area
via a probe contained in a head that also incor-
porates an ultrasound transducer that helps
localize the area of injury during the treatment
and focus very accurately in the area of interest.
Horses with soft tissue injuries usually receive
three treatments at three weeks intervals. For
bony injuries, there is usually one treatment,
but sometimes depending on the response to
the treatment, there can be additional sessions.
Each treatment usually consists on 2,000
shocks delivered to the area of injury. Horses
received this treatment under sedation as the
shock waves cause some pain while being
administered.
Many chronically lame horses become
sounder with ESWT treatment, although no
one knows with any degree of certainty why the
treatment seems to work. It is thought that
increased blood flow may help with the healing
process.
Dr. Seco and Dr. Virginia Reef will present
their findings at the Sports Medicine Sympo-
sium in the spring of 2003.
Extracorporeal High Energy Shock Wave Therapy
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MSG to laboratory animals can produce
delayed, but permanent defects in hormone
secretion and drug metabolism, contributing to
long-term, serious health consequences.
Another of their studies found that prenatal
administration of either one of the two sub-
stances can result in a multitude of long-term
reproductive, growth, hepatic and neural dys-
functions. One finding, in particular, is disturb-
ing: neonatal administration of phenobarbital
can induce a delayed but permanent elevation
in the activities of several hepatic drug metabo-
lizing enzymes. These enzymes break down
specific substances, when their activities are
elevated, these drugs are broken down faster.
One would expect such elevated activity right
after administration of phenobarbital, but not
much later. However, it appears that at sexual
maturity, when gender dependent differences
in drug metabolism appear, the hepatic drug
metabolizing enzymes are induced again and
remain overexpressed for the rest of life. In rats
exposed as neonates to phenobarbital this
results in a shorter lifespan, and a great increase
in tumor formation.
Neonatal exposure to MSG has a different
effect on growth hormone production. It caus-
es a permanent reduction in the secretion of
growth hormone which leads to a reduced pro-
duction of the drug-metabolizing enzymes.
This hampers the metabolization of drugs and
toxic substance. The reduced quantity of
growth hormone leads to stunted growth and
irreversible obesity. Like phenobarbital, defects
resulting from neonatal exposure to MSG are
not apparent until adulthood.
Dr. Shapiro and his group are currently
working to answer these questions: How do the
chemicals induce the defects? How are the
defects expressed? The group has observed
that, when the production of growth hormone
is disturbed, the level of drug metabolizing
enzymes is affected. They found that in male
and female rats, prenatally exposed to pheno-
barbital, there were permanent defects in the
expression of these enzymes. The mechanism
by which the abnormal profile of growth  hor-
mone disrupts the enzyme expression is not
known, and the group proposes to investigate
it.
It is known that men, exposed perinatally to
phenobarbital, have a considerable higher inci-
dence of delayed puberty, undescended testes,
and genital abnormalities. In women this expo-
sure leads to irregular menstrual cycles and
problems during pregnancy. Both sexes score
lower on IQ tests as adults. Further, phenobar-
bital is a known carcinogen that induces the
overexpression of selected hepatic enzymes that
can increase the metabolism of innocuous
compounds into carcinogenic and toxic
metabolites. Perinatal exposure to the barbitu-
rate has been reported to subsequently increase
the risk of cancer in adult rats and children.
Phenobarbital and MSG are just two sub-
stances that can have an impact on drug
metabolism. There are many other compounds
that are in drugs or food and their impact on
human metabolism is unknown. One of these,
aspartame, is used widely as a sweetener. “Our
studies with rats have shown that the sweeten-
er, containing an amino acid like MSG, could
produce subtle developmental defects in
growth hormone secretion,” explains Dr.
Shapiro. “It is estimated that children consume
almost 100 mg of aspartame per kg of body
weight per day, a level approaching the adverse
doses found in animal studies. Children under
the age of five are particularly vulnerable, their
hepatic and neuroendocrine differentiation are
still incomplete and early constant exposure to
low levels of food additives could permanently
alter hormone secretion, the expression of
hepatic drug metabolizing enzymes and/or
their responses to inducing agents. Such effects
could unknowingly affect the efficacy of drug
therapy or the susceptibility to chemically-
induced cancers in adulthood.”
Sports Medicine Symposium for Equine Practitioners
Saturday,March 22 and Sunday,March 23,2003
Registration/participation fee: $175 Saturday only; $200 Saturday plus Sunday wet labs.
March 22:Lecture Topics
Performance problems in the Race Horse—Dr. Ben Martin
Performance problems in the Sport Horse—Dr. Elizabeth Davidson
Cardiovascular Problems in the Equine Athlete—Dr. Virginia Reef
Obscure Lameness Problems in the Equine Athlete—Dr. Mike Ross
Exercise Physiology: What You Need to Know—Dr. Ric Birks
Evaluation of Cardiac Output and Myocardial Function in Exercising Horses—Dr. Mary
Durando
Muscular Problems associated with Poor Performance—Dr. Jill Beech
Motion Correction for Standing Equine MRI—Dr. Lexi Lawrence
Suspensory desmitis and its response to treatment with high energy extracorporeal shock wave
therapy—Dr. Olga Seco
Where we stand and where we are moving toward with respiratory surgery—Dr. Eric Parente
All presenters with exception of Dr. Mary Durando are New Bolton Center faculty/clinicians
March 23:Wet Labs 
Station A - High speed treadmill demonstration
Station B - Endoscopic evaluation of upper airway dysfunction detected at speed
Case discussions at 2 stations - half of participants in each group
Station C - Lameness videos
Station D - Scintigraphic case evaluations
CE credits: 8 hours
Registration limited to 80 for Saturday sessions, 60 (max.) for Sunday wet labs
Saturday Sessions will be held in Woerner Amphitheatre, George D. Widener Hospital for
Large Animals, New Bolton Center, Kennett Square, Pa.
Wet Labs to be held in the new Scott Equine Sports Medicine Building, Jeffords Treadmill
Building, Scintigraphy station, New Bolton Center.
Please contact Office of Development, New Bolton Center, for detailed information and regis-
tration forms. Tel: 610-444-5800. ext. 2500 or email Patricia Hall at <phall@vet.upenn.edu>
